Xia Ziwei, Fu Zhinan, Li Li, Ma Enguang, Sun Liang, Ma Qinyu, Guo Xuhong
State Key Laboratory of Chemical Engineering, East China University of Science and Technology, Shanghai 200237, China.
School of Chemistry and Chemical Engineering, Shihezi University, Shihezi 832003, China.
Polymers (Basel). 2022 May 24;14(11):2133. doi: 10.3390/polym14112133.
Metal coordination-driven nanocomplexes are known to be responsive to physiologically relevant stimuli such as pH, redox, temperature or light, making them well-suited for antitumor drug delivery. The ever-growing demand for such nanocomplexes necessitates the design of a scalable approach for their production. In this study, we demonstrate a novel coordination self-assembly strategy, termed flash nanocomplexation (FNC), which is rapid and efficient for the fabrication of drug-loaded nanoparticles (NPs) in a continuous manner. Based on this strategy, biocompatible chitosan (CS) and Cu2+ can be regarded anchors to moor the antitumor drug (curcumin, Cur) through coordination, resulting in curcumin-loaded chitosan nanocomplex (Cur-loaded CS nanocomplex) with a narrow size distribution (PDI < 0.124) and high drug loading (up to 41.75%). Owing to the excellent stability of Cur-loaded CS nanocomplex at neutral conditions (>50 days), premature Cur leakage was limited to lower than 1.5%, and pH-responsive drug release behavior was realized in acidic tumor microenvironments. An upscaled manufacture of Cur-loaded CS nanocomplex is demonstrated with continuous FNC, which shows an unprecedented method toward practical applications of nanomedicine for tumor therapy. Furthermore, intracellular uptake study and cytotoxicity experiments toward H1299 cells demonstrates the satisfied anticancer efficacy of the Cur-loaded CS nanocomplex. These results confirm that coordination-driven FNC is an effective method that enables the rapid and scalable fabrication of antitumor drugs.
已知金属配位驱动的纳米复合物对生理相关刺激(如pH值、氧化还原、温度或光)有响应,这使其非常适合用于抗肿瘤药物递送。对这类纳米复合物的需求不断增长,因此需要设计一种可扩展的生产方法。在本研究中,我们展示了一种新型的配位自组装策略,称为快速纳米复合(FNC),它能以连续的方式快速高效地制备载药纳米颗粒(NP)。基于该策略,生物相容性壳聚糖(CS)和Cu2+可作为锚定物,通过配位作用固定抗肿瘤药物(姜黄素,Cur),从而得到尺寸分布窄(PDI<0.124)且载药量高(高达41.75%)的载姜黄素壳聚糖纳米复合物(载Cur的CS纳米复合物)。由于载Cur的CS纳米复合物在中性条件下具有出色的稳定性(>50天),Cur的过早泄漏限制在1.5%以下,并且在酸性肿瘤微环境中实现了pH响应性药物释放行为。通过连续FNC展示了载Cur的CS纳米复合物的放大生产,这为纳米医学在肿瘤治疗中的实际应用提供了一种前所未有的方法。此外,对H1299细胞的细胞内摄取研究和细胞毒性实验证明了载Cur的CS纳米复合物具有令人满意的抗癌效果。这些结果证实,配位驱动的FNC是一种有效的方法,能够快速且可扩展地制备抗肿瘤药物。
Int J Biol Macromol. 2020-12-15
Curr Pharm Biotechnol. 2021
Int J Nanomedicine. 2017-3-29
Angew Chem Int Ed Engl. 2022-4-19
J Nanobiotechnology. 2022-1-4
Mater Today (Kidlington). 2021
Adv Sci (Weinh). 2021-8
J Am Chem Soc. 2021-6-2